{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T10:31:49Z","timestamp":1786962709408,"version":"build-2736575974"},"reference-count":58,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T00:00:00Z","timestamp":1600732800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Dutch Ministry of Agriculture, Nature and Food Quality","award":["1691063000, 1630047700 and 1600025-01"],"award-info":[{"award-number":["1691063000, 1630047700 and 1600025-01"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.vaccine.2020.08.072","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T17:44:22Z","timestamp":1599759862000},"page":"7108-7117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Safety and efficacy of inactivated African horse sickness (AHS) vaccine formulated with different adjuvants"],"prefix":"10.1016","volume":"38","author":[{"given":"Piet A.","family":"van Rijn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieke A.","family":"Maris-Veldhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miemie","family":"Grobler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel M.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baltus J.","family":"Erasmus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis H.","family":"Maartens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiaan A.","family":"Potgieter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.08.072_b0005","unstructured":"Theiler A. African Horse sickness. Science bulletin 1921;19."},{"key":"10.1016\/j.vaccine.2020.08.072_b0010","doi-asserted-by":"crossref","unstructured":"Erasmus BJ. The pathogenesis of African Horsesickness. Proceedings of the 3rd Int Conf Equine Infectious Diseases. Paris: Karger, Basel; 1973. p. 1-11.","DOI":"10.1159\/000393512"},{"key":"10.1016\/j.vaccine.2020.08.072_b0015","first-page":"139","article-title":"The isolation and identification of further antigenic types of African horsesickness virus","volume":"29","author":"Howell","year":"1962","journal-title":"Onderstepoort J Vet Res"},{"key":"10.1016\/j.vaccine.2020.08.072_b0020","first-page":"465","article-title":"Immunological types of horsesickness virus and their significance in immunization","volume":"27","author":"McIntosh","year":"1958","journal-title":"Onderstepoort J Vet Res"},{"key":"10.1016\/j.vaccine.2020.08.072_b0025","article-title":"African Horse Sickness Virus","author":"van Rijn","year":"2019","journal-title":"Reference Module in Life Sciences: Elsevier"},{"key":"10.1016\/j.vaccine.2020.08.072_b0030","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/vr.101083","article-title":"Outbreaks of African horse sickness in Senegal, and methods of control of the 2007 epidemic","volume":"172","author":"Diouf","year":"2013","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2020.08.072_b0035","first-page":"7","article-title":"The Transmission of Blue-Tongue andn Horse Sickness by Culicoides","volume":"19","author":"Du Toit","year":"1944","journal-title":"Onderstepoort J Vet Science and Animal Industry"},{"key":"10.1016\/j.vaccine.2020.08.072_b0040","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1365-2915.2000.00245.x","article-title":"African horse sickness epidemiology: vector competence of south african Culicoides species for virus serotypes 3, 5 and 8","volume":"14","author":"Venter","year":"2000","journal-title":"Med Vet Entomol"},{"key":"10.1016\/j.vaccine.2020.08.072_b0045","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2915.2007.00706.x","article-title":"Virus recovery rates for wild-type and live-attenuated vaccine strains of African horse sickness virus serotype 7 in orally infected South African Culicoides species","volume":"21","author":"Venter","year":"2007","journal-title":"Med Vet Entomol"},{"key":"10.1016\/j.vaccine.2020.08.072_b0050","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrmicro1090","article-title":"Climate change and the recent emergence of bluetongue in Europe","volume":"3","author":"Purse","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2020.08.072_b0055","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1017\/S0950268809990367","article-title":"Assessing the impact of climate change on vector-borne viruses in the EU through the elicitation of expert opinion","volume":"138","author":"Gale","year":"2010","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2020.08.072_b0060","first-page":"216","article-title":"Horse sickness","volume":"56","author":"Rafyi","year":"1961","journal-title":"Bull Off Int Epizoot"},{"key":"10.1016\/j.vaccine.2020.08.072_b0065","first-page":"23","article-title":"A review of the aetiology and pathologyof African horsesickness","volume":"25","author":"Mirchamsy","year":"1973","journal-title":"Arch Hessarek Iran."},{"key":"10.1016\/j.vaccine.2020.08.072_b0070","first-page":"329","article-title":"The 1960 epizootic of African horsesickness in the Middle East and SW Asia","volume":"31","author":"Howell","year":"1960","journal-title":"J South Afr Vet Assoc"},{"key":"10.1016\/j.vaccine.2020.08.072_b0075","doi-asserted-by":"crossref","DOI":"10.1111\/tbed.13625","article-title":"African horse sickness: Its emergence in Thailand and potential threat to other Asian countries","author":"Lu","year":"2020","journal-title":"Transboundary and emerging diseases"},{"key":"10.1016\/j.vaccine.2020.08.072_b0080","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0378-1135(92)90041-Q","article-title":"African horse sickness in Spain","volume":"33","author":"Rodriguez","year":"1992","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2020.08.072_b0085","first-page":"26","article-title":"African horsesickness and the epizootic in Spain 1987","volume":"10","author":"Lubroth","year":"1988","journal-title":"Equine Pract."},{"key":"10.1016\/j.vaccine.2020.08.072_b0090","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1051\/vetres:2004021","article-title":"African horse sickness","volume":"35","author":"Mellor","year":"2004","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2020.08.072_b0095","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1136\/vr.162.13.422-a","article-title":"Culicoides chiopterus as a potential vector of bluetongue virus in Europe","volume":"162","author":"Dijkstra","year":"2008","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2020.08.072_b0100","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/vr.161.16.564","article-title":"Potential new Culicoides vector of bluetongue virus in northern Europe","volume":"161","author":"Meiswinkel","year":"2007","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2020.08.072_b0105","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00436-007-0519-6","article-title":"First occurrence of Culicoides obsoletus-transmitted Bluetongue virus epidemic in Central Europe","volume":"101","author":"Mehlhorn","year":"2007","journal-title":"Parasitol Res"},{"key":"10.1016\/j.vaccine.2020.08.072_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023066","article-title":"Transmission and control of African horse sickness in The Netherlands: a model analysis","volume":"6","author":"Backer","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.08.072_b0115","article-title":"Comparative Risk Analysis of Two Culicoides-Borne Diseases in Horses: Equine Encephalosis More Likely to Enter France than African Horse Sickness","author":"Faverjon","year":"2016","journal-title":"Transboundary Emerging Dis"},{"key":"10.1016\/j.vaccine.2020.08.072_b0120","doi-asserted-by":"crossref","DOI":"10.3390\/v11090844","article-title":"African horse sickness: a review of current understanding and vaccine development","author":"Dennis","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2020.08.072_b0125","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.3201\/eid2212.160718","article-title":"African horse sickness caused by genome reassortment and reversion to virulence of live, attenuated vaccine viruses, South Africa, 2004\u20132014","volume":"22","author":"Weyer","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2020.08.072_b0130","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0168-1656(99)00121-2","article-title":"Diva vaccines that reduce virus transmission","volume":"73","author":"van Oirschot","year":"1999","journal-title":"J Biotechnol"},{"key":"10.1016\/j.vaccine.2020.08.072_b0135","article-title":"African horse sickness virus NS4 is a nucleocytoplasmic protein that localizes to PML nuclear bodies","author":"Boughan","year":"2020","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2020.08.072_b0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124281","article-title":"Characterising non-structural protein NS4 of African horse sickness virus","volume":"10","author":"Zwart","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.08.072_b0145","unstructured":"Attoui H, Mertens P, Becnel J, Belaganahalli S, Bergoin M, Brussaard CP, et al. Virus taxonomy. In Ninth Report of the International Committee on Taxonomy of Viruses. In: King AMQ, Adams MJ, Carstens EB, Lefkowitz E, editors. Oxford, UK2011. p. 1338."},{"key":"10.1016\/j.vaccine.2020.08.072_b0150","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pep.2013.07.005","article-title":"Multiple large foreign protein expression by a single recombinant baculovirus: A system for production of multivalent vaccines","volume":"91","author":"Kanai","year":"2013","journal-title":"Protein Expr Purif"},{"issue":"Pt 9","key":"10.1016\/j.vaccine.2020.08.072_b0155","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1099\/0022-1317-77-9-2053","article-title":"Recombinant baculovirus-synthesized African horsesickness virus (AHSV) outer-capsid protein VP2 provides protection against virulent AHSV challenge","volume":"77","author":"Roy","year":"1996","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2020.08.072_b0160","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13567-018-0600-4","article-title":"Safety and immunogenicity of plant-produced African horse sickness virus-like particles in horses","volume":"49","author":"Dennis","year":"2018","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2020.08.072_b0165","doi-asserted-by":"crossref","first-page":"7003","DOI":"10.1016\/j.vaccine.2018.09.065","article-title":"A single dose of African horse sickness virus (AHSV) VP2 based vaccines provides complete clinical protection in a mouse model","volume":"36","author":"Aksular","year":"2018","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2020.08.072_b0170","doi-asserted-by":"crossref","unstructured":"van de Water SG, van Gennip RG, Potgieter CA, Wright IM, van Rijn PA. VP2 exchange and NS3\/NS3a deletion in African horse sickness virus (AHSV) in development of Disabled Infectious Single Animal vaccine candidates for AHSV. Journal of virology. 2015;89:8764-72.","DOI":"10.1128\/JVI.01052-15"},{"key":"10.1016\/j.vaccine.2020.08.072_b0175","doi-asserted-by":"crossref","unstructured":"van Rijn PA, van de Water SG, Feenstra F, van Gennip RG. Requirements and comparative analysis of reverse genetics for bluetongue virus (BTV) and African horse sickness virus (AHSV). Virology journal. 2016;13:119.","DOI":"10.1186\/s12985-016-0574-7"},{"key":"10.1016\/j.vaccine.2020.08.072_b0180","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1016\/j.vaccine.2017.06.023","article-title":"Protective efficacy of multivalent replication-abortive vaccine strains in horses against African horse sickness virus challenge","volume":"35","author":"Lulla","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.08.072_b0185","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.vaccine.2018.03.003","article-title":"African horse sickness virus (AHSV) with a deletion of 77 amino acids in NS3\/NS3a protein is not virulent and a safe promising AHS Disabled Infectious Single Animal (DISA) vaccine platform","volume":"36","author":"van Rijn","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.08.072_b0190","article-title":"Live attenuated African horsesickness virus WO 2016\/071850","author":"Potgieter","year":"2014","journal-title":"Google Patents"},{"key":"10.1016\/j.vaccine.2020.08.072_b0195","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0264-410X(94)90052-3","article-title":"Further studies on the efficacy of an inactivated African horse sickness serotype 4 vaccine","volume":"12","author":"House","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.08.072_b0200","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0168-1702(95)00061-T","article-title":"The use of African horse sickness virus NS3 protein, expressed in bacteria, as a marker to differentiate infected from vaccinated horses","volume":"38","author":"Laviada","year":"1995","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2020.08.072_b0205","series-title":"Development, production and quality control of an industrial inactivated vaccine against African horse sickness virus serotype 4","first-page":"874","author":"Dubourget","year":"1992"},{"key":"10.1016\/j.vaccine.2020.08.072_b0210","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/j.jevs.2016.02.215","article-title":"Production of an African Horse Sickness killed vaccine containing all 9 serotypes","volume":"39","author":"Wernery","year":"2016","journal-title":"J Equine Veterinary Sci"},{"key":"10.1016\/j.vaccine.2020.08.072_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jevs.2020.102967","article-title":"African horse sickness fever in vaccinated horses: short communication","volume":"88","author":"Wernery","year":"2020","journal-title":"J Equine Vet Sci."},{"key":"10.1016\/j.vaccine.2020.08.072_b0220","first-page":"89","article-title":"Inactivated and adjuvanted vaccine for the control of the African horse sickness virus serotype 9 infection: evaluation of efficacy in horses and guinea-pig model","volume":"49","author":"Lelli","year":"2013","journal-title":"Vet Ital."},{"key":"10.1016\/j.vaccine.2020.08.072_b0225","first-page":"55","article-title":"Immunogenicity of two adjuvant formulations of an inactivated African horse sickness vaccine in guinea-pigs and target animals","volume":"48","author":"Ronchi","year":"2012","journal-title":"Vet Ital."},{"key":"10.1016\/j.vaccine.2020.08.072_b0230","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cimid.2007.07.006","article-title":"Vaccines against bluetongue in Europe","volume":"31","author":"Savini","year":"2008","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2020.08.072_b0235","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1016\/j.vaccine.2018.05.044","article-title":"Diagnostic DIVA tests accompanying the disabled infectious single animal (DISA) vaccine platform for African horse sickness","volume":"36","author":"van Rijn","year":"2018","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2020.08.072_b0240","unstructured":"OIE A. Manual of diagnostic tests and vaccines for terrestrial animals. Office international des epizooties, paris, France. 2008:1092-106."},{"key":"10.1016\/j.vaccine.2020.08.072_b0245","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF01315592","article-title":"Binary Ethylenimine as an Inactivant for Foot-and-Mouth-Disease Virus and Its Application for Vaccine Production","volume":"47","author":"Bahnemann","year":"1975","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2020.08.072_b0250","unstructured":"Anonymous. MontanideTM Gel 01. Technical Bulletin, 2008."},{"key":"10.1016\/j.vaccine.2020.08.072_b0255","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.provac.2011.07.015","article-title":"Adjuvant formulation for companion animals vaccines","volume":"4","author":"Deville","year":"2011","journal-title":"Procedia Vaccinol"},{"key":"10.1016\/j.vaccine.2020.08.072_b0260","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.addr.2004.02.004","article-title":"Current status and potential application of ISCOMs in veterinary medicine","volume":"56","author":"Morein","year":"2004","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2020.08.072_b0265","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.vetimm.2011.11.019","article-title":"ISCOM-matrix-based equine influenza (EIV) vaccine stimulates cell-mediated immunity in the horse","volume":"145","author":"Paillot","year":"2012","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2020.08.072_b0270","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/icb.1996.2","article-title":"ISCOMs (immunostimulating complexes): the first decade","volume":"74","author":"Barr","year":"1996","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2020.08.072_b0275","first-page":"171","article-title":"The cytopathic action of Bluetongue virus on tissue cultures and its application to the detection of antibodies in the serum of sheep","volume":"27","author":"Haig","year":"1956","journal-title":"Onderstepoort J Vet Res"},{"key":"10.1016\/j.vaccine.2020.08.072_b0280","unstructured":"Merial. Merial's bluetongue vaccine - information for veterinary professionals and farmers. 2015."},{"key":"10.1016\/j.vaccine.2020.08.072_b0285","doi-asserted-by":"crossref","unstructured":"van Gennip RG, van de Water SG, van Rijn PA. Bluetongue virus nonstructural protein NS3\/NS3a is not essential for virus replication. PloS one. 2014;9:e85788.","DOI":"10.1371\/journal.pone.0085788"},{"key":"10.1016\/j.vaccine.2020.08.072_b0290","doi-asserted-by":"crossref","first-page":"12222","DOI":"10.1128\/JVI.02183-14","article-title":"A synthetic biology approach for a vaccine platform against known and newly emerging serotypes of bluetongue virus","volume":"88","author":"Nunes","year":"2014","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20311245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20311245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:49:36Z","timestamp":1759402176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20311245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":58,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0264410X20311245"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.08.072","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of inactivated African horse sickness (AHS) vaccine formulated with different adjuvants","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.08.072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}